{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T06:26:58Z","timestamp":1793946418718,"version":"4.8.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100021171","name":"Basic and Applied Basic Research Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2024A1515012796"],"award-info":[{"award-number":["2024A1515012796"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018568","name":"Special Fund Project for Science and Technology Innovation Strategy of Guangdong Province","doi-asserted-by":"publisher","award":["STKJ2023008"],"award-info":[{"award-number":["STKJ2023008"]}],"id":[{"id":"10.13039\/501100018568","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32301069"],"award-info":[{"award-number":["32301069"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011840","name":"Shantou University Medical College","doi-asserted-by":"publisher","award":["510858066"],"award-info":[{"award-number":["510858066"]}],"id":[{"id":"10.13039\/501100011840","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - General Subjects"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.bbagen.2026.130941","type":"journal-article","created":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T00:58:52Z","timestamp":1774486732000},"page":"130941","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["ST6Gal1 influences the esophageal squamous cell carcinoma resistance to IFN-\u03b3 by regulating the expression of IFN-\u03b3 receptor 1"],"prefix":"10.1016","volume":"1870","author":[{"given":"Kaixin","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nianzhu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingshu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiwei","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaobin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanli","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenzhe","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.bbagen.2026.130941_bb0005","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s40364-024-00718-2","article-title":"Global, regional, and national burden of esophageal cancer: a systematic analysis of the global burden of disease study 2021","volume":"13","author":"Jin","year":"2025","journal-title":"Biomark. Res."},{"issue":"1","key":"10.1016\/j.bbagen.2026.130941_bb0010","doi-asserted-by":"crossref","first-page":"5208","DOI":"10.1038\/s41598-025-89060-7","article-title":"Blood trace elements in association with esophageal squamous cell carcinoma risk, aggressiveness and prognosis in a high incidence region of China","volume":"15","author":"Qiu","year":"2025","journal-title":"Sci. Rep."},{"issue":"11","key":"10.1016\/j.bbagen.2026.130941_bb0015","doi-asserted-by":"crossref","first-page":"3379","DOI":"10.1016\/j.apsb.2021.03.008","article-title":"Advances and challenges in the treatment of esophageal cancer","volume":"11","author":"He","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"issue":"41","key":"10.1016\/j.bbagen.2026.130941_bb0020","doi-asserted-by":"crossref","first-page":"5337","DOI":"10.1038\/onc.2016.34","article-title":"The tumor microenvironment in esophageal cancer","volume":"35","author":"Lin","year":"2016","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.bbagen.2026.130941_bb0025","doi-asserted-by":"crossref","first-page":"5291","DOI":"10.1038\/s41467-021-25539-x","article-title":"Dissecting esophageal squamous-cell carcinoma ecosystem by single-cell transcriptomic analysis","volume":"12","author":"Zhang","year":"2021","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.bbagen.2026.130941_bb0030","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s12943-020-01294-3","article-title":"Cytokine-chemokine network driven metastasis in esophageal cancer; promising avenue for targeted therapy","volume":"20","author":"Bhat","year":"2021","journal-title":"Mol. Cancer"},{"issue":"4","key":"10.1016\/j.bbagen.2026.130941_bb0035","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1158\/0008-5472.CAN-07-5021","article-title":"Negative feedback regulation of IFN-\u03b3 pathway by IFN regulatory factor 2 in Esophageal cancers","volume":"68","author":"Wang","year":"2008","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbagen.2026.130941_bb0040","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s40364-020-00228-x","article-title":"Roles of IFN-\u03b3 in tumor progression and regression: a review","volume":"8","author":"Jorgovanovic","year":"2020","journal-title":"Biomark. Res."},{"key":"10.1016\/j.bbagen.2026.130941_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113683","article-title":"Role of interferon-gamma (IFN-\u03b3) and IFN-\u03b3 receptor 1\/2 (IFN\u03b3R1\/2) in regulation of immunity, infection, and cancer development: IFN-\u03b3-dependent or independent pathway","volume":"155","author":"Ding","year":"2022","journal-title":"Biomed. Pharmacother."},{"issue":"7","key":"10.1016\/j.bbagen.2026.130941_bb0050","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1158\/2159-8290.CD-20-1571","article-title":"Loss of optineurin drives Cancer immune evasion via palmitoylation-dependent IFNGR1 lysosomal sorting and degradation","volume":"11","author":"Du","year":"2021","journal-title":"Cancer Discov."},{"issue":"5","key":"10.1016\/j.bbagen.2026.130941_bb0055","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1093\/glycob\/cwaa110","article-title":"Regulation of ST6GAL1 sialyltransferase expression in cancer cells","volume":"31","author":"Dorsett","year":"2021","journal-title":"Glycobiology"},{"issue":"1","key":"10.1016\/j.bbagen.2026.130941_bb0060","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/s12014-024-09516-2","article-title":"Identification of serum N-glycans signatures in three major gastrointestinal cancers by high-throughput N-glycome profiling","volume":"21","author":"Liu","year":"2024","journal-title":"Clin. Proteomics"},{"issue":"7","key":"10.1016\/j.bbagen.2026.130941_bb0065","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.bcp.2012.01.007","article-title":"Sialylation of epidermal growth factor receptor regulates receptor activity and chemosensitivity to gefitinib in colon cancer cells","volume":"83","author":"Park","year":"2012","journal-title":"Biochem. Pharmacol."},{"issue":"5","key":"10.1016\/j.bbagen.2026.130941_bb0070","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1074\/jbc.M117.801480","article-title":"ST6Gal-I sialyltransferase promotes tumor necrosis factor (TNF)-mediated cancer cell survival via sialylation of the TNF receptor 1 (TNFR1) death receptor","volume":"293","author":"Holdbrooks","year":"2018","journal-title":"J. Biol. Chem."},{"issue":"3\u20134","key":"10.1016\/j.bbagen.2026.130941_bb0075","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1007\/s10555-012-9359-7","article-title":"Regulation of the metastatic cell phenotype by sialylated glycans","volume":"31","author":"Schultz","year":"2012","journal-title":"Cancer Metastasis Rev."},{"issue":"8","key":"10.1016\/j.bbagen.2026.130941_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2024.114591","article-title":"Nuclear HMGB1 is critical for CD8 T cell IFN-\u03b3 production and anti-tumor immunity","volume":"43","author":"Xu","year":"2024","journal-title":"Cell Rep."},{"issue":"19","key":"10.1016\/j.bbagen.2026.130941_bb0085","doi-asserted-by":"crossref","DOI":"10.3390\/ijms231911937","article-title":"Caspase 3 and cleaved caspase 3 expression in Tumorogenesis and its correlations with prognosis in head and neck Cancer: a systematic review and Meta-analysis","volume":"23","author":"Silva","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.bbagen.2026.130941_bb0090","doi-asserted-by":"crossref","first-page":"6268","DOI":"10.1038\/s41467-020-20019-0","article-title":"Immune suppressive landscape in the human esophageal squamous cell carcinoma microenvironment","volume":"11","author":"Zheng","year":"2020","journal-title":"Nat. Commun."},{"issue":"10","key":"10.1016\/j.bbagen.2026.130941_bb0095","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1016\/j.celrep.2017.02.037","article-title":"CD95\/Fas increases stemness in Cancer cells by inducing a STAT1-dependent type I interferon response","volume":"18","author":"Qadir","year":"2017","journal-title":"Cell Rep."},{"issue":"2","key":"10.1016\/j.bbagen.2026.130941_bb0100","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/sj.bjc.6603849","article-title":"Development of IFN-\u03b3 resistance is associated with attenuation of SOCS genes induction and constitutive expression of SOCS 3 in melanoma cells","volume":"97","author":"Fojtova","year":"2007","journal-title":"Br. J. Cancer"},{"issue":"7","key":"10.1016\/j.bbagen.2026.130941_bb0105","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2024-009410","article-title":"IFN\u03b3 mediates the resistance of tumor cells to distinct NK cell subsets","volume":"12","author":"Hofman","year":"2024","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.bbagen.2026.130941_bb0110","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1190333","article-title":"Dysregulation in IFN-\u03b3 signaling and response: the barricade to tumor immunotherapy","volume":"14","author":"Han","year":"2023","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.bbagen.2026.130941_bb0115","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.canlet.2013.04.029","article-title":"IFN-\u03b3 selectively exerts pro-apoptotic effects on tumor-initiating label-retaining colon cancer cells","volume":"336","author":"Ni","year":"2013","journal-title":"Cancer Lett."},{"issue":"14","key":"10.1016\/j.bbagen.2026.130941_bb0120","doi-asserted-by":"crossref","first-page":"3737","DOI":"10.1158\/0008-5472.CAN-19-0596","article-title":"Low-dose IFN\u03b3 induces tumor cell stemness in tumor microenvironment of non-small cell lung Cancer","volume":"79","author":"Song","year":"2019","journal-title":"Cancer Res."},{"issue":"2","key":"10.1016\/j.bbagen.2026.130941_bb0125","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S0002-9440(10)64871-7","article-title":"Interferon-gamma reduces melanosomal antigen expression and recognition of melanoma cells by cytotoxic T cells","volume":"160","author":"Le Poole","year":"2002","journal-title":"Am. J. Pathol."},{"issue":"2","key":"10.1016\/j.bbagen.2026.130941_bb0130","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.cell.2016.08.069","article-title":"Loss of IFN-\u03b3 pathway genes in tumor cells as a mechanism of resistance to anti-CTLA-4 therapy","volume":"167","author":"Gao","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.bbagen.2026.130941_bb0135","first-page":"1352","article-title":"IFN-gamma in the tumor microenvironment: dual roles in cancer progression and therapy","volume":"24","author":"Cui","year":"2025","journal-title":"EXCLI J."},{"issue":"1","key":"10.1016\/j.bbagen.2026.130941_bb0140","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/s41416-020-01126-7","article-title":"Insights into the role of sialylation in cancer progression and metastasis","volume":"124","author":"Dobie","year":"2021","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.bbagen.2026.130941_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.mcpro.2021.100160","article-title":"Integrated systems analysis of the murine and human pancreatic Cancer Glycomes reveals a tumor-promoting role for ST6GAL1","volume":"20","author":"Kurz","year":"2021","journal-title":"Mol. Cell. Proteomics"},{"issue":"13","key":"10.1016\/j.bbagen.2026.130941_bb0150","doi-asserted-by":"crossref","first-page":"3978","DOI":"10.1158\/0008-5472.CAN-15-2834","article-title":"The tumor-associated glycosyltransferase ST6Gal-I regulates stem cell transcription factors and confers a Cancer stem cell phenotype","volume":"76","author":"Schultz","year":"2016","journal-title":"Cancer Res."},{"issue":"6","key":"10.1016\/j.bbagen.2026.130941_bb0155","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1007\/s13402-025-01118-w","article-title":"ST6GAL1-mediated sialylation inhibits the antitumor immune response in colorectal cancer","volume":"48","author":"Shi","year":"2025","journal-title":"Cell. Oncol."},{"issue":"3","key":"10.1016\/j.bbagen.2026.130941_bb0160","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1053\/j.gastro.2022.11.018","article-title":"N-glycosylation regulates intrinsic IFN-\u03b3 resistance in colorectal Cancer: implications for immunotherapy","volume":"164","author":"Krug","year":"2023","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.bbagen.2026.130941_bb0165","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2013.38","article-title":"Phosphorylation of signal transducer and activator of transcription 1 reduces bortezomib-mediated apoptosis in cancer cells","volume":"4","author":"Kao","year":"2013","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.bbagen.2026.130941_bb0170","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1038\/s41467-024-54791-0","article-title":"Remodelling of the immune landscape by IFN\u03b3 counteracts IFN\u03b3-dependent tumour escape in mouse tumour models","volume":"16","author":"Lau","year":"2025","journal-title":"Nat. Commun."},{"issue":"19","key":"10.1016\/j.bbagen.2026.130941_bb0175","doi-asserted-by":"crossref","first-page":"6118","DOI":"10.1158\/1078-0432.CCR-11-0482","article-title":"The two faces of interferon-\u03b3 in cancer","volume":"17","author":"Zaidi","year":"2011","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.bbagen.2026.130941_bb0180","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/s41423-021-00735-3","article-title":"IFN\u03b3 signaling integrity in colorectal cancer immunity and immunotherapy","volume":"19","author":"Du","year":"2022","journal-title":"Cell. Mol. Immunol."}],"container-title":["Biochimica et Biophysica Acta (BBA) - General Subjects"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304416526000413?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304416526000413?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T05:34:50Z","timestamp":1793943290000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304416526000413"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":36,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S0304416526000413"],"URL":"https:\/\/doi.org\/10.1016\/j.bbagen.2026.130941","relation":{},"ISSN":["0304-4165"],"issn-type":[{"value":"0304-4165","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"ST6Gal1 influences the esophageal squamous cell carcinoma resistance to IFN-\u03b3 by regulating the expression of IFN-\u03b3 receptor 1","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - General Subjects","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbagen.2026.130941","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"130941"}}